<DOC>
	<DOCNO>NCT02270931</DOCNO>
	<brief_summary>The purpose study obtain sufficient specimen correlate clinical data well-controlled prospective clinical trial collect longitudinal specimen subject diagnose stage breast cancer .</brief_summary>
	<brief_title>A Prospective Longitudinal Breast Cancer Study</brief_title>
	<detailed_description>The study objectives describe : 1 . Obtain serum plasma specimen longitudinally collect minimum 130 subject diagnose breast cancer currently undergo treatment follow-up . Specimens use evaluate CA 15-3 assay , currently development , aid monitoring recurrence progressive disease . 2 . To store remain specimen use future cancer research evaluate yet undetermined biomarkers development IVDs , include additional CA 15-3 assay , monitor course disease therapy subject diagnose breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Males female , age≥ 18 year Histologic/pathologic confirmation breast cancer Any stage disease : Newly diagnose , stable , disease progression , surveillance Any treatment time point : Treatment naïve , currently receive complete therapy breast cancer include active monitoring . Individuals history malignant disease breast cancer resect great 5 year ago currently remission eligible . Able understand willing provide inform consent Males female , age &lt; 18 year No histologic/pathologic confirmation breast cancer Any concurrent malignancy basal squamous cell skin cancer , insitu cervical cancer , breast cancer . Treatment plan few three visit expect 3 year ' time Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>